Cancer Immunotherapy Using AIRE Conditioning of the Tumor Epitopeome

{"T-cell":[0,135,154,159,188,227],"immune":[1,72,170,215],"tolerance":[2],"is":[3,54],"established":[4],"in":[5,17,52,68,108,111,115,118],"part":[6],"through":[7],"the":[8,11,18,25,64,84,97,140,175],"activity":[9],"of":[10,24,30,43,50,66,81,124,143,187,198,210,226],"Auto-immune":[12],"Regulator":[13],"(AIRE)":[14],"transcription":[15],"factor":[16],"medullary":[19],"thymic":[20],"epithelial":[21],"cells":[22,39,120,133],"(mTEC)":[23],"thymus.":[26],"AIRE":[27,51,67,77,116,211,222],"induces":[28],"expression":[29,117,209,223],"peripheral":[31],"tissue-specific":[32],"self-antigens":[33],"for":[34,185],"presentation":[35],"to":[36,40,55,70,134,169,177,193,214],"naïve":[37],"T":[38,45,102,195],"promote":[41],"activation/deletion":[42],"autoreactive":[44],"cells.":[46,103],"This":[47],"traditional":[48],"role":[49,65],"mTECs":[53,69],"prevent":[56],"autoimmunity.":[57],"Herein,":[58],"we":[59,105],"demonstrate":[60],"that":[61,76,208],"tumors":[62,165],"mimic":[63],"evade":[71],"rejection.":[73],"We":[74],"found":[75],"induced":[78],"a":[79,151,157,218],"profile":[80,123],"\\"selfness\\"":[82],"at":[83],"RNA":[85],"and":[86,129,190,224],"protein":[87],"levels":[88],"which,":[89],"when":[90],"presented":[91],"on":[92],"major":[93],"histocompatibility":[94],"complexes,":[95],"shielded":[96],"tumor":[98,119,132],"from":[99],"inherently":[100],"self-tolerized":[101],"Moreover,":[104],"describe":[106],"an":[107],"vivo":[109],"immunotherapy":[110,148],"which":[112],"engineered":[113],"changes":[114],"altered":[121],"their":[122],"selfness,":[125],"exposing":[126],"both":[127],"AIRE-modified":[128],"parental":[130],"unmodified":[131],"attack.":[136],"Therefore,":[137],"by":[138],"re-setting":[139],"immunological":[141],"selfness":[142],"cancer":[144],"cells,":[145],"this":[146],"AIRE-mediated":[147],"1)":[149],"converted":[150],"highly":[152],"tolerized":[153],"compartment":[155],"into":[156],"tumor-reactive":[158],"population;":[160],"2)":[161],"conferred":[162],"upon":[163],"non-immunogenic":[164,202],"de":[166],"novo":[167],"sensitivity":[168],"checkpoint":[171],"blockade;":[172],"3)":[173],"removed":[174],"need":[176],"identify":[178],"potentially":[179],"immunogenic":[180],"tumor-associated":[181],"antigens":[182],"as":[183],"targets":[184],"generation":[186],"responses;":[189],"4)":[191],"lead":[192],"potent":[194],"cell-mediated":[196],"rejection":[197],"aggressive,":[199],"immunologically":[200],"cold,":[201],"tumors.":[203],"Patient":[204],"RNA-sequencing":[205],"data":[206],"showed":[207],"predicted":[212],"response":[213],"therapies":[216],"with":[217],"strong":[219],"correlation":[220],"between":[221],"markers":[225],"receptor":[228],"signaling,":[229],"suggesting":[230],"our":[231],"studies":[232],"have":[233],"therapeutic":[234],"translational":[235],"value.":[236]}